Ami Shah Rajeshbhai
About Ami Shah Rajeshbhai
Data last updated:
Ami Shah Rajeshbhai is a Director at Parmax Pharma Limited (since 2018). The company operates in Pharma. Parmax Pharma Limited reported revenue of ₹28.24 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Parmax Pharma Limited L24231GJ1994PLC023504 | Director | 17 Jun 2018 | 1994 | ₹28.24 Cr (FY 2025) | Active |
Board colleagues of Ami Shah Rajeshbhai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhakti Rameshbhai Aghera | Parmax Pharma Limited | Company Secretary | |
| Keyur Dineshbhai Vora | Parmax Pharma Limited | Cfo | |
| Nikhil Sureshchandra Uchat | 08427983 | Parmax Pharma Limited | Director |
| Pradeep Ramniklal Gosalia | 01130646 | Parmax Pharma Limited | Director |
| Salma Badrudin Thobhani | 11616267 | Parmax Pharma Limited | Director |
| Umang Alkesh Gosalia | 05153830 | Parmax Pharma Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ami Shah Rajeshbhai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ami Shah Rajeshbhai
Ami Shah Rajeshbhai currently holds 1 directorship: Parmax Pharma Limited (Director, since 17 Jun 2018, revenue ₹28.24 Cr (FY 2025)).
Ami Shah Rajeshbhai was first appointed on 17 Jun 2018 as Director at Parmax Pharma Limited.
The current boards of Ami Shah Rajeshbhai's companies include Bhakti Rameshbhai Aghera (Parmax Pharma Limited), Keyur Dineshbhai Vora (Parmax Pharma Limited), Nikhil Sureshchandra Uchat (Parmax Pharma Limited), Pradeep Ramniklal Gosalia (Parmax Pharma Limited), Salma Badrudin Thobhani (Parmax Pharma Limited), Umang Alkesh Gosalia (Parmax Pharma Limited).